In fact, several anti-cancer drugs target MCSF1R (macrophage colony-stimulating factor 1 receptor), MSCGFR (mast/stem cell growth factor receptor), POTPKABL1 (proto-oncogene tyrosine-protein kinase ABL1) and VEGFR2 (vascular endothelial growth factor receptor 2), among others. The gene discussed is ABL1; the disease is cancer.